Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Over the last 2 decades, aspiration pneumonia and Alzheimer disease-related mortality have significantly decreased in older ...

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine ...

Hypertension-related vascular dementia mortality rates have increased over the past 15 years, especially among Black and African American individuals.

Increased physical activity, energy expenditure, and reduced sedentary behavior are protective in lowering the risk for neuropsychiatric diseases.

Patients with relapsing MS treated with tolebrutinib vs teriflunomide had a clear reduction in disability accumulation with ...

Two women neurologists reflect on their journeys into the field of neurology and share advice for aspiring women neurologists ...

Psychological prehabilitation may improve 4 postoperative outcomes: reduced length of stay (LOS), pain, anxiety, and depression.

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

Tesla (T) magnetic resonance imaging changes management in more than half of adult candidates for epilepsy surgery.

What role could vitamin E play in the treatment of tardive dyskinesia, and what should patients know about managing their condition?

Zunveyl (benzgalantamine) is now available for the treatment of mild to moderate dementia of the Alzheimer type in adults.